Across TCGA pan-cancer cohorts, RPL23AP76 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of RPL23AP76’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL23AP76 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL23AP76 is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

COAD are the cancer types where RPL23AP76 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL23AP76 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	−0.018	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: RPL23AP76 RNA expression & survival · all RPL23AP76 data types